Last update 01 Nov 2024
Shenzhen Rosso Pharmaceutical Co., Ltd.

Shenzhen Rosso Pharmaceutical Co., Ltd.

Private Company|
1994|
Guangdong Sheng, China
|
www.rossopharm.com

Overview

Tags

Otorhinolaryngologic Diseases
Nervous System Diseases
Digestive System Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Immune System Diseases1
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Infectious Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
GR(Glucocorticoid receptor)1

Related

1
Drugs associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
Triamcinolone Acetonide
Target
GR
Mechanism
GR agonists
Active Org.
Harrow, Inc.Harrow, Inc. [+14]
Originator Org.
Apothecon BV
Active Indication
Uveitic Macular Edema [+70]
Inactive Indication
Age Related Macular Degeneration [+13]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date04 Jan 1960
1
Clinical Trials associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
CTR20210035 / CompletedPhase 3
评估玻璃体内注射用曲安奈德在玻璃体手术中用于玻璃体可视化的有效性和安全性的多中心临床研究
[Translation] A multicenter clinical study to evaluate the efficacy and safety of intravitreal triamcinolone acetonide for vitreous visualization during vitreous surgery
100 Clinical Results associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shenzhen Rosso Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Triamcinolone Acetonide
 ( GR )		-
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free